化脓性汗腺炎中的胰岛素抵抗:一项病例对照研究
这项横断面病例对照研究纳入137名受试者(76例化脓性汗腺炎患者与61名年龄和性别匹配的对照),计算稳态模型评估的胰岛素抵抗指数(HOMA-IR)。患者组HOMA-IR中位数及胰岛素抵抗患病率均显著高于对照组,校正年龄、性别和体质指数后化脓性汗腺炎仍是HOMA-IR升高的显著因素。
要点
- 化脓性汗腺炎患者HOMA-IR中位数2.0(IQR 1.0-3.6),高于对照组的1.5(IQR 0.9-2.3),P=0.01。
- 患者组胰岛素抵抗患病率43.4%,高于对照组的16.4%,P=0.001。
- 按疾病严重程度分组后,各组间HOMA-IR值和胰岛素抵抗患病率无显著差异。
核心结论
- 研究结果显示化脓性汗腺炎患者中胰岛素抵抗的发生频率升高,作者建议对化脓性汗腺炎患者进行胰岛素抵抗评估并据此管理。
研究设计与样本
- 横断面病例对照研究,纳入137名受试者,其中化脓性汗腺炎患者76例、年龄和性别匹配的对照61名。
- 记录人口学数据、患者临床检查、人体测量指标、心血管危险因素和实验室检查,并通过测定空腹血糖和胰岛素水平计算稳态模型评估的胰岛素抵抗指数(HOMA-IR)。
主要发现
- 化脓性汗腺炎患者HOMA-IR中位数(IQR)为2.0(1.0-3.6),显著高于对照组的1.5(0.9-2.3),P=0.01。
- 患者组胰岛素抵抗患病率为43.4%,显著高于对照组的16.4%,P=0.001。
- 在校正年龄、性别和体质指数(BMI)后的线性回归多变量分析中,化脓性汗腺炎仍是HOMA-IR较高的显著因素,数值为2.51(0.18)对1.92(0.21),P=0.04。
- 按疾病严重程度分组的化脓性汗腺炎患者之间,HOMA-IR值和胰岛素抵抗患病率无显著差异。
临床怎么用
- 作者建议对化脓性汗腺炎患者进行胰岛素抵抗评估并据此管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The association between chronic inflammatory diseases, such as rheumatoid arthritis and psoriasis, and insulin resistance (IR) has been well established. Hidradenitis suppurativa (HS) is a chronic inflammatory cutaneous disease that affects the apocrine gland-bearing areas of the body. OBJECTIVE: We aimed to determine the prevalence of IR in patients with HS. METHODS: This cross-sectional, case-control study enrolled 137 subjects, 76 patients with HS and 61 age- and gender-matched controls. Demographic data, clinical examination of HS patients, anthropometric measures, cardiovascular risk factors and laboratory studies were recorded. The homeostasis model assessment of IR (HOMA-IR) was calculated in all participants by measuring fasting plasma glucose and insulin levels. RESULTS: The median (IQR) HOMA-IR value in HS patients was significantly higher [2.0 (1.0-3.6)] than in controls [1.5 (0.9-2.3)] (P = 0.01). The prevalence of IR was significantly higher in cases (43.4%) compared with controls (16.4%) (P = 0.001). In the linear regression multivariable analysis after adjusting for age, sex and body mass index (BMI), HS remained as a significant factor for a higher HOMA-IR [2.51 (0.18) vs 1.92(0.21); P = 0.04]. The HOMA-IR value and the prevalence of IR did not differ significantly among HS patients grouped by severity of the disease. CONCLUSION: Our results show an increased frequency of IR in HS. Thus, we suggest HS patients to be evaluated for IR and managed accordingly.
引用
- Vilanova I, Hernández JL, Mata C, et al. Insulin resistance in hidradenitis suppurativa: a case-control study. J Eur Acad Dermatol Venereol. 2018. PMID: 29485215. doi:10.1111/jdv.14894
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。